Abstract
Ofloxacin has been used for prevention and treatment of burn infection in 40 burnt subjects. Clinical response and microbiological efficacy reached 82.5 and 83%, respectively. The highest efficacy was observed in patients with burnt body surface area not more than 25%. The drug is recommended as a prophylactic modality in acute burn toxemia.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adult
-
Aged
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents / therapeutic use*
-
Bacteria / isolation & purification
-
Bacteriological Techniques
-
Burns / complications
-
Burns / drug therapy*
-
Female
-
Humans
-
Male
-
Middle Aged
-
Ofloxacin / administration & dosage
-
Ofloxacin / therapeutic use*
-
Time Factors
-
Wound Infection / drug therapy*
-
Wound Infection / microbiology
-
Wound Infection / prevention & control
Substances
-
Anti-Infective Agents
-
Ofloxacin